Imagine a world in which infections and diseases in humans, animals and plants are impossible to treat—where infections caused by a simple scratch to the hand, contracted in childbirth or from a visit to the dentist, could cause death within days. This is not some science fiction dystopia; it could happen unless we take immediate action to reduce antimicrobial resistance (AMR).
AMR occurs when bacteria, viruses, fungi and parasites no longer respond to medicines, making infections difficult or impossible to treat, increasing the risk of disease spread, severe illness and death.
While the development of resistance is a natural biological process that will occur sooner or later, with every drug, the process has been accelerated by faulty practices and flawed assumptions. In many cases, our behaviour is responsible for this situation—the prescribing practices of doctors and pharmacists, poor infection control in health facilities, the weakness of many drug regulatory authorities, and practices used in industrialised food production.
As well as making infections harder to treat, AMR makes other medical procedures—routine surgery, caesarean sections, cancer chemotherapy—much riskier. Patients who can currently be cured will die. Interventions we take for granted will become dangerous or impossible.
39 million lives at risk
Without action to tackle antimicrobial resistance, by 2050, bacterial AMR will cause 39 million deaths. That’s three deaths every minute. It will incur $ 1tn in additional health care costs. By 2030, without action, it will result in annual losses to global GDP of somewhere between $ 1tn and $3.4tn.
In my own region, the Eastern Mediterranean, in 2021 alone, more than 1.7 million people died as a result of sepsis, with 373,000 of those deaths shown to be associated with AMR.